您的位置: 首页 > 农业专利 > 详情页

HEPATITIS B ANTIVIRAL AGENTS
专利权人:
Inc.;Enanta Pharmaceuticals
发明人:
Yao-Ling Qiu,Hui Cao,Wei Li,Xiaowen Peng,Meizhong Jin,Jorden Kass,Xuri Gao,Yat Sun Or
申请号:
US16204166
公开号:
US20190216808A1
申请日:
2018.11.29
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充